Clinical application of a contingent screening strategy for trisomies with cell-free DNA: a pilot study

BACKGROUND: Different strategies have been designed for clinical implementation of cell-free DNA (cfDNA) testing. We aimed to evaluate the performance of a contingent strategy based on conventional screening and offering cfDNA to the intermediate-risk group, for the screening for trisomies 21, 18 an...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Durán, María Ángeles, Bernabeu García, Andrea, Calero, Inés, Ramis Fossas, Jordi, Illescas, Tamara, Avilés, María Teresa, Maiz, Nerea, Carreras, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676567/
https://www.ncbi.nlm.nih.gov/pubmed/31370808
http://dx.doi.org/10.1186/s12884-019-2434-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676567/
https://www.ncbi.nlm.nih.gov/pubmed/31370808
http://dx.doi.org/10.1186/s12884-019-2434-0

Ejemplares similares